• Popular
    • Medicine
    • Radiology
    • Cardiology
    • Surgery
    • Nanomedicine
    • Military Medicine
    • Rehab
  • Categories
    • Exclusive
    • A-D
      • Anesthesiology
      • Art
      • Cardiac Surgery
      • Cardiology
      • Critical Care
      • Dentistry
      • Dermatology
      • Diagnostics
    • E-I
      • Emergency Medicine
      • ENT
      • Genetics
      • Geriatrics
      • GI
      • Informatics
    • M-N
      • Medicine
      • Military Medicine
      • Nanomedicine
      • Net News
      • Neurology
      • Neurosurgery
      • Nuclear Medicine
    • O-P
      • Ob/Gyn
      • Oncology
      • Ophthalmology
      • Orthopedic Surgery
      • Pathology
      • Pediatrics
      • Plastic Surgery
      • Psychiatry
      • Public Health
    • R-V
      • Radiation Oncology
      • Radiology
      • Rehab
      • Reproductive Medicine
      • Space Medicine
      • Sports Medicine
      • Surgery
      • Thoracic Surgery
      • Urology
      • Vascular Surgery
  • SUBSCRIBE
  • Submit PR
  • About
  • Follow
    • Facebook
    • Twitter
    • Linkedin
    • Youtube
    • Instagram
    • RSS
  • Submit PR
  • Log in
Medgadget
Medgadget
  • Popular
    • Medicine
      Levels Is Making Metabolism and Blood Glucose Tracking Accessible To Everyone

      Levels Is Making Metabolism and Blood Glucose Tracking Accessible To Everyone

      CRISPR Combined with Glowing Proteins for Viral Detection

      CRISPR Combined with Glowing Proteins for Viral Detection

      Biomimetic Construct Models Burn Injuries

      Biomimetic Construct Models Burn Injuries

      Moving Cells Using Ultrasound

      Moving Cells Using Ultrasound

    • Radiology
      Imaging Technique Reveals Contraction Patterns During Labor

      Imaging Technique Reveals Contraction Patterns During Labor

      Moving Cells Using Ultrasound

      Moving Cells Using Ultrasound

      Ultrasound Catheter to Treat Hypertension

      Ultrasound Catheter to Treat Hypertension

      Antibacterial Smart Sutures Visible in CT Scans

      Antibacterial Smart Sutures Visible in CT Scans

    • Cardiology
      Scientists Grow Electrodes Inside The Body

      Scientists Grow Electrodes Inside The Body

      Patient-Specific Soft Robotic Heart Replicas for Treatment Planning

      Patient-Specific Soft Robotic Heart Replicas for Treatment Planning

      Tiny Patch for Cardiac Ultrasound Imaging

      Tiny Patch for Cardiac Ultrasound Imaging

      Belt Monitors Heart Failure Patients

      Belt Monitors Heart Failure Patients

    • Surgery
      Biomimetic Construct Models Burn Injuries

      Biomimetic Construct Models Burn Injuries

      Exclusive Look at HandX Robotic-Assisted Surgical Device from Human Xtensions

      Exclusive Look at HandX Robotic-Assisted Surgical Device from Human Xtensions

      Self-Assembling Peptides as a Bioink

      Self-Assembling Peptides as a Bioink

      3D Bioengineered Skin Grafts Fit Complex Anatomy

      3D Bioengineered Skin Grafts Fit Complex Anatomy

    • Nanomedicine
      Bottlebrush Particle for Synergistic Drug Combinations

      Bottlebrush Particle for Synergistic Drug Combinations

      Extra Hot Nanoparticles for Cancer Therapy

      Extra Hot Nanoparticles for Cancer Therapy

      Making Tumors Tastier for the Immune System

      Making Tumors Tastier for the Immune System

      Improved Membrane Coating for Anti-Cancer Nanoparticles

      Improved Membrane Coating for Anti-Cancer Nanoparticles

    • Military Medicine
      Device Measures Hemoglobin More Accurately in Dark Skin

      Device Measures Hemoglobin More Accurately in Dark Skin

      Fingertip Sensor Measures Lithium Levels in Sweat

      Fingertip Sensor Measures Lithium Levels in Sweat

      Fabric Makes Electricity from Movement to Power Wearables

      Fabric Makes Electricity from Movement to Power Wearables

      Wearable Uses Microneedles to Track Metabolism

      Wearable Uses Microneedles to Track Metabolism

    • Rehab
      Empowering Stroke Survivors: Interview with Kirsten Carroll, CEO at Kandu Health

      Empowering Stroke Survivors: Interview with Kirsten Carroll, CEO at Kandu Health

      Smart Walking Stick for Visually Impaired People

      Smart Walking Stick for Visually Impaired People

      Implantable Device Adheres to Muscle, Treats Atrophy

      Implantable Device Adheres to Muscle, Treats Atrophy

      Non-Invasive Spinal Modulation for Cerebral Palsy

      Non-Invasive Spinal Modulation for Cerebral Palsy

  • Categories
    • Exclusive
    • A-D
      • Anesthesiology
      • Art
      • Cardiac Surgery
      • Cardiology
      • Critical Care
      • Dentistry
      • Dermatology
      • Diagnostics
    • E-I
      • Emergency Medicine
      • ENT
      • Genetics
      • Geriatrics
      • GI
      • Informatics
    • M-N
      • Medicine
      • Military Medicine
      • Nanomedicine
      • Net News
      • Neurology
      • Neurosurgery
      • Nuclear Medicine
    • O-P
      • Ob/Gyn
      • Oncology
      • Ophthalmology
      • Orthopedic Surgery
      • Pathology
      • Pediatrics
      • Plastic Surgery
      • Psychiatry
      • Public Health
    • R-V
      • Radiation Oncology
      • Radiology
      • Rehab
      • Reproductive Medicine
      • Space Medicine
      • Sports Medicine
      • Surgery
      • Thoracic Surgery
      • Urology
      • Vascular Surgery
  • SUBSCRIBE
  • Submit PR
  • About
  • Log in
  • Submit PR
  • Follow
    • Facebook
    • Twitter
    • Linkedin
    • Youtube
    • Instagram
    • RSS

The Increasing Prevalence of Cardiovascular Diseases Will Drive the Drug-Eluting Stents Market to US$ 11.28 Billion By 2030, Says Growth Plus Reports

March 17th, 2023 Growth Plus Reports Releases

The latest report from Growth Plus Reports analyzes the product type, applications, demand, and key players and provides a SWOT analysis of the global drug-eluting stents market.

The drug-eluting stents market report helps finalize the optimum distribution methods for certain products and potential markets for future product launches. The report analyzes the buying and supply patterns that influence the production strategy. This report provides insights into a detailed Table of content and charts representing important data, statistics, trends, and competitive landscape information in this market.

Request Free Sample Copy of the Research Report: https://www.growthplusreports.com/inquiry/request-sample/drug-eluting-stents-market/7888

Drug-eluting Stents Market Scope

Report Attribute Details
Market size value in 2021 US$ 6.91 billion
Revenue forecast in 2030 US$ 11.28 billion
Growth Rate CAGR of 5.6% from 2022 to 2030
Base year for estimation 2021
Forecast period 2022-2030
Segments covered drug coating, application, and region.
Regional scope North America, Europe, Asia Pacific, and the Rest of the World (ROW)

Key Takeaways:

  • The increasing prevalence of cardiovascular diseases will drive market revenue growth.
  • Increasing demand for minimally invasive procedures will drive demand for drug-eluting stents.
  • North America dominates the global drug-eluting stents market.

Market Drivers

The increasing geriatric population and the high risk of developing vascular diseases will drive the revenue growth of the drug-eluting stents market. Furthermore, the increasing prevalence of cardiovascular and vascular diseases, unhealthy lifestyles, poor eating habits, and a lack of exercise are expected to boost the market revenue growth rate. Apart from this, the increasing demand for minimally invasive procedures, the adoption of advanced technologies, and the rise in research and development activities are expected to support the market’s revenue growth.

Market Segmentation

Growth Plus Reports has analyzed the global drug-eluting stents market from three perspectives: Drug Coating, Application, and Region.

Drug Coating Segmentation: Based on the drug coating, the global drug-eluting stents market is segmented into polymer-based coatings and polymer-free coatings. The polymer-free coating segment dominates the market with the largest revenue share because it has advantages such as lower in-stent restenosis rates, quicker drug eluting rates, and increased therapeutic effectiveness.

Application Segmentation: Based on the application, the drug-eluting stents market is segmented into coronary artery disease and peripheral artery disease. The coronary artery disease segment dominates the market because of the increasing prevalence of chronic diseases like diabetes and high blood pressure, the increased demand for minimally invasive procedures, and lower complications compared to other treatment options.

Regional Growth Dynamics

Based on the region, the global drug-eluting stents market is segmented into North America, Europe, Asia Pacific, and the Rest of the World.

North America dominates the drug-eluting stents market with the largest revenue share. The region’s growing geriatric population, rising prevalence of cardiovascular diseases, rising obesity, rising diabetes prevalence, unhealthy lifestyles, rising demand for minimally invasive procedures, healthcare infrastructure, and the presence of top market players are responsible for North America’s significant revenue share in the global market.

Request for Customization –  https://www.growthplusreports.com/inquiry/customization/drug-eluting-stents-market/7888

Competitive Landscape

The major players operating in the global drug-eluting stents market are:

  • Boston Scientific Corporation
  • Abbott Laboratories
  • Terumo Corporation
  • Medtronic Plc
  • Biotronik SE & Co. KG
  • Biosensors International Group Ltd
  • Cook Medical
  • Shandong J.W. Medical Systems Ltd
  • MicroPort Scientific Corporation
  • Stentys SA
  • Lepu Medical Technology Co. ltd
  • Cardionovum GmbH
  • Kyoto Medical Planning Co. Ltd.

The drug-eluting stents devices market is competitive, with several international companies. The top players in the market focus on technological advancements, invest in research and development activities and use mergers and acquisitions to strengthen their market presence.

Recent developments:

  • Medtronic Plc launched its upgraded Onyx Frontier drug-eluting stent in August 2022. (DES). It is a novel interventional treatment option for coronary artery disease (CAD) with an updated delivery system, increased flexibility, and a reduced crossing profile.

 

  • MedAlliance acquired conditional FDA Investigational Device Exemption (IDE) permission in August 2022 to begin clinical trials for their novel sirolimus-eluting balloon (SELUTION SLR) for treating superficial femoral artery occlusive disease (SFA).

Table of Content

  1. INTRODUCTION
    1. Market Ecosystem
    2. Timeline Under Consideration
      1. Historical Years – 2020
      2. Base Year – 2021
      3. Forecasted Years – 2022 to 2030
    3. Currency Used in the Report
  2. RESEARCH METHODOLOGY 
    1. Research Approach
    2. Data Collection Methodology
    3. Data Sources
      1. Secondary Sources
      2. Primary Sources
    4. Market Estimation Approach
      1. Bottom Up
      2. Top Down
    5. Market Forecasting Model
    6. Limitations and Assumptions
  3. PREMIUM INSIGHTS
    1. Current Market Trends (COVID-19 Perspective)
    2. Key Players & Competitive Positioning (2021)
  4. MARKET DYNAMICS
    1. Drivers
    2. Restraints/Challenges
    3. Opportunities
  5. GLOBAL DRUG-ELUTING STENTS MARKET – ANALYSIS & FORECAST, BY DRUG COATING 
    1. Polymer-based Coatings
      1. Biodegradable Polymers
      2. Non-biodegradable Polymers
    2. Polymer-free Coatings
      1. Micro porous Surface
      2. Microstructured Surface
      3. Slotted Tubular Surface
      4. Nanoporous Surface

TOC Continued…

Buy this Premium Research Report: https://www.growthplusreports.com/checkout-7888

VALUE PROPOSITIONS RELATED TO THE REPORT:

  • Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
  • Comprehensive quantitative and qualitative insights at segment and sub-segment level
  • Covid 19 impact trends and perspective
  • Granular insights at global/regional/country level
  • Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
  • Blanket coverage on competitive landscape
  • Winning imperatives
  • Exhaustive coverage on ‘Strategic Developments’ registered by leading players of the market

CUSTOMIZATION OPTIONS:

  • Distributor Landscape Assessment
  • Pricing Intelligence
  • Customer Base Assessment
  • Investment & Initiatives Analysis
  • ‘Business Profile’ of Key Players

Schedule a call with our analyst: https://appoint.ly/s/salesZ3Jvd3RocGx1c3JlcG9ydHMuY29t/introduction

Visit our report store at – https://www.growthplusreports.com/report-store

Browse related reports:

Adalimumab Biosimilars Market by Product (Amgevita, Hyrimoz, Imraldi), by Application (Rheumatoid Arthritis, Psoriatic Arthritis,) Distribution Channel (Hospital Pharmacy, Retail Pharmacy) – Global Outlook & Forecast 2022-2030

Orthopedic Digit Implants Market by Product Type (Metatarsal Joint Implants, Metacarpal Joint Implants), Material (Pyrocarbon, Titanium), End-user (Hospitals & Speciality Orthopedic Clinics) – Global Outlook and Forecast 2020-2030

Human Liver Model Market by Type (Liver Organoids, Liver-on-a-chip, 3D Bioprinting, 2D Models), Application (Academics, Drug Discovery), End-users (Research Institutes & Academics, Pharmaceutical Companies) – Global Outlook & Forecast 2022-2030

Healthcare 3D Printing Market by Technology (Electron Beam Melting, Laser Beam Melting), Component (3D Printer, 3D Bioprinter), Application (Surgical Guides, Prosthetics), End User (Hospitals, Pharmaceutical & Biotechnology Companies) – Global Outlook & Forecast Period 2022-2030

Complement-Targeted Therapeutics Market by Disease Type (Paroxysmal Nocturnal Hemoglobinuria, Atypical Hemolytic Uremic Syndrome (aHUS)), Distribution Channel (Hospital Pharmacies, Retail Pharmacies) – Global Outlook & Forecast 2022-2030

 

About Us:

Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).

Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.

We were awarded by the prestigious CEO Magazine as “Most Innovative Healthcare Market Research Company in 2020.

Contact:
Manan Sethi
Director, Market Insights
Email: sales@growthplusreports.com

256 Chapman Road

STE 105-4, Newark,

New Castle – 19702, USA
Phone no: +1 888 550 5009
Web: https://www.growthplusreports.com/

Sign up and submit a press release

Sponsored
Venture builder BHV Partners launches Conus Airway to improve anaesthesia  and respiratory surgery

Venture builder BHV Partners launches Conus Airway to improve anaesthesia and respiratory surgery

FDA Expands Indications for Use of FibroScan® for Comprehensive Liver Management

FDA Expands Indications for Use of FibroScan® for Comprehensive Liver Management

machineMD and Varjo revolutionize the diagnosis of brain disorders with a VR-based eye-tracking solution 

machineMD and Varjo revolutionize the diagnosis of brain disorders with a VR-based eye-tracking solution 

Ax-Surgi Hemostat gets FDA Clearance for Surgical Bleeding Control

Ax-Surgi Hemostat gets FDA Clearance for Surgical Bleeding Control

Clarius Report Finds 85% of Clinicians Believe Ultrasound Leads to Better Patient Outcomes

Clarius Report Finds 85% of Clinicians Believe Ultrasound Leads to Better Patient Outcomes

interviews & reviews
Levels Is Making Metabolism and Blood Glucose Tracking Accessible To Everyone

Levels Is Making Metabolism and Blood Glucose Tracking Accessible To Everyone

Imagene Profiles Cancer Biomarkers in Real Time

Imagene Profiles Cancer Biomarkers in Real Time

Empowering Stroke Survivors: Interview with Kirsten Carroll, CEO at Kandu Health

Empowering Stroke Survivors: Interview with Kirsten Carroll, CEO at Kandu Health

Alpha TAU Killing Tumors With Highly Targeted Alpha Radiation

Alpha TAU Killing Tumors With Highly Targeted Alpha Radiation

Neuroimmune Modulation for Inflammatory Disease: Interview with Dr. Simhambhatla, President and CEO of SetPoint Medical

Neuroimmune Modulation for Inflammatory Disease: Interview with Dr. Simhambhatla, President and CEO of SetPoint Medical

Exclusive Look at HandX Robotic-Assisted Surgical Device from Human Xtensions

Exclusive Look at HandX Robotic-Assisted Surgical Device from Human Xtensions

Balance Boards to Stay Active in the Offfice: Interview with Joel Heath, CEO of FluidStance 

Balance Boards to Stay Active in the Offfice: Interview with Joel Heath, CEO of FluidStance 

  • Subscribe
  • Contact us
  • Submit
  • About
  • Back to top
Medgadget

Medical technologies transform the world! Join us and see the progress in real time. At Medgadget, we report the latest technology news, interview leaders in the field, and file dispatches from medical events around the world since 2004.

  • About
  • Editorial policies
  • Contact
  • Terms of Service
  • Privacy
  • Submit press release
  • Advertise
© Medgadget, Inc. All rights reserved. | The Medical Revolution Will Be Blogged.
Please support this website by adding us to your whitelist in your ad blocker. Ads are what helps us bring you premium content! Thank you!
Posting....
  • Facebook
  • Twitter
  • LinkedIn
  • Reddit
  • Email